Avicanna to Present at the Life Science Investor Forum June 20th, 2024
Investors, advisors and analysts, will have the opportunity to attend in-person or participate online at VirtualInvestorConferences.com Investors, advisors and analysts, will have the opportunity to attend in-person or participate online at VirtualInvestorCon…
TORONTO, June 18, 2024 (GLOBE NEWSWIRE) — Avicanna Inc. (Avicanna or Company) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing, and commerc…